US Stock MarketDetailed Quotes

West Pharmaceutical Services (WST)

Watchlist

306.160
-3.540-1.14%

Close Apr 24 16:00 ET

306.160
0.0000.00%

Post 17:25 ET

21.63BMarket Cap40.93P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

West Pharmaceutical Services (WST) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-30.53%89.9M

15.52%754.8M

32.09%251.1M

9.49%197.2M

7.33%177.1M

9.48%129.4M

-15.85%653.4M

-20.49%190.1M

-21.73%180.1M

-2.48%165M

Net income from continuing operations

54.57%138.8M

0.20%493.7M

1.54%132.1M

2.94%140M

18.42%131.8M

-22.12%89.8M

-16.97%492.7M

-5.04%130.1M

-15.69%136M

-28.24%111.3M

Operating gains losses

----

35.71%-9.9M

----

-196.15%-15.4M

----

Depreciation and amortization

13.00%45.2M

10.30%171.4M

15.48%47M

6.97%43M

6.43%41.4M

12.36%40M

13.18%155.4M

13.37%40.7M

12.61%40.2M

14.08%38.9M

Deferred tax

----

-291.43%-13.7M

----

-109.33%-3.5M

----

Other non cash items

190.48%1.9M

57.45%-2M

-102.00%-100K

261.90%3.4M

17.95%-3.2M

43.24%-2.1M

-570.00%-4.7M

-65.52%5M

-90.91%-2.1M

33.90%-3.9M

Change In working capital

-103,000.00%-102.9M

2,651.72%79.8M

247.66%81.7M

2,200.00%2.1M

-129.08%-4.1M

100.29%100K

114.22%2.9M

-12.64%23.5M

-100.40%-100K

155.73%14.1M

-Change in receivables

----

111.73%6.9M

----

-1,570.00%-58.8M

----

-Change in inventory

----

-249.52%-62.8M

----

411.11%42M

----

-Change in payables and accrued expense

----

517.24%17.9M

----

-34.09%2.9M

----

-Change in other current assets

----

267.24%9.7M

----

72.77%-5.8M

----

-Change in other working capital

----

378.32%108.1M

----

276.67%22.6M

----

Cash from discontinued investing activities

Operating cash flow

-30.53%89.9M

15.52%754.8M

32.09%251.1M

9.49%197.2M

7.33%177.1M

9.48%129.4M

-15.85%653.4M

-20.49%190.1M

-21.73%180.1M

-2.48%165M

Investing cash flow

Cash flow from continuing investing activities

40.11%-42.7M

24.50%-285.9M

27.39%-76.1M

22.90%-63.3M

25.69%-75.2M

21.30%-71.3M

-2.71%-378.7M

3.68%-104.8M

14.21%-82.1M

-23.26%-101.2M

Capital expenditure reported

40.11%-42.7M

24.16%-285.9M

27.45%-76.1M

22.14%-63.3M

24.95%-75.2M

21.30%-71.3M

-4.14%-377M

3.50%-104.9M

15.14%-81.3M

-32.89%-100.2M

Net other investing changes

----

74.63%-1.7M

200.00%100K

-900.00%-800K

----

Cash from discontinued investing activities

Investing cash flow

40.11%-42.7M

24.50%-285.9M

27.39%-76.1M

22.90%-63.3M

25.69%-75.2M

21.30%-71.3M

-2.71%-378.7M

3.68%-104.8M

14.21%-82.1M

-23.26%-101.2M

Financing cash flow

Cash flow from continuing financing activities

-110.00%-308.7M

70.27%-185.1M

83.02%-11.7M

82.14%-11.5M

93.17%-14.9M

45.76%-147M

-35.47%-622.6M

63.64%-68.9M

-188.79%-64.4M

-23.47%-218.3M

Net issuance payments of debt

-50.00%-300K

96.01%-1.1M

-200.00%-300K

91.43%-300K

98.71%-300K

71.43%-200K

-1,050.00%-27.6M

85.71%-100K

-483.33%-3.5M

-4,560.00%-23.3M

Net common stock issuance

-120.66%-300.1M

75.86%-136.8M

99.63%-200K

99.81%-100K

99.73%-500K

50.07%-136M

-25.58%-566.6M

69.17%-54.6M

-86.48%-52.4M

-7.34%-187.2M

Cash dividends paid

-3.95%-15.8M

-3.55%-61.2M

-3.27%-15.8M

-4.14%-15.1M

-3.42%-15.1M

-3.40%-15.2M

-3.68%-59.1M

-3.38%-15.3M

-3.57%-14.5M

-3.55%-14.6M

Proceeds from stock option exercised by employees

70.45%7.5M

-44.34%18.2M

48.39%4.6M

-33.33%4M

-23.53%5.2M

-73.81%4.4M

-35.88%32.7M

0.00%3.1M

-70.59%6M

-44.26%6.8M

Net other financing activities

----

-110.00%-4.2M

--0

----

---2M

----

Cash from discontinued financing activities

Financing cash flow

-110.00%-308.7M

70.27%-185.1M

83.02%-11.7M

82.14%-11.5M

93.17%-14.9M

45.76%-147M

-35.47%-622.6M

63.64%-68.9M

-188.79%-64.4M

-23.47%-218.3M

Net cash flow

Beginning cash position

63.29%791.3M

-43.25%484.6M

28.03%628.5M

14.23%509.7M

-32.83%404.2M

-43.25%484.6M

-4.52%853.9M

-45.37%490.9M

-43.97%446.2M

-32.10%601.8M

Current changes in cash

-194.15%-261.5M

181.58%283.8M

895.73%163.3M

264.29%122.4M

156.31%87M

63.48%-88.9M

-571.62%-347.9M

127.70%16.4M

-70.03%33.6M

-72.24%-154.5M

Effect of exchange rate changes

-198.82%-8.4M

207.01%22.9M

97.80%-500K

-132.43%-3.6M

1,781.82%18.5M

197.70%8.5M

-287.72%-21.4M

-256.55%-22.7M

213.27%11.1M

-266.67%-1.1M

End cash Position

29.00%521.4M

63.29%791.3M

28.03%628.5M

14.23%509.7M

-32.83%404.2M

-43.25%484.6M

-45.37%490.9M

-43.97%446.2M

Free cash flow

-18.76%47.2M

69.65%468.9M

105.40%175M

35.53%133.9M

57.25%101.9M

110.51%58.1M

-33.32%276.4M

-34.66%85.2M

-26.43%98.8M

-30.92%64.8M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-30.53%89.9M	15.52%754.8M	32.09%251.1M	9.49%197.2M	7.33%177.1M	9.48%129.4M	-15.85%653.4M	-20.49%190.1M	-21.73%180.1M	-2.48%165M
Net income from continuing operations	54.57%138.8M	0.20%493.7M	1.54%132.1M	2.94%140M	18.42%131.8M	-22.12%89.8M	-16.97%492.7M	-5.04%130.1M	-15.69%136M	-28.24%111.3M
Operating gains losses	----	35.71%-9.9M	----	----	----	----	-196.15%-15.4M	----	----	----
Depreciation and amortization	13.00%45.2M	10.30%171.4M	15.48%47M	6.97%43M	6.43%41.4M	12.36%40M	13.18%155.4M	13.37%40.7M	12.61%40.2M	14.08%38.9M
Deferred tax	----	-291.43%-13.7M	----	----	----	----	-109.33%-3.5M	----	----	----
Other non cash items	190.48%1.9M	57.45%-2M	-102.00%-100K	261.90%3.4M	17.95%-3.2M	43.24%-2.1M	-570.00%-4.7M	-65.52%5M	-90.91%-2.1M	33.90%-3.9M
Change In working capital	-103,000.00%-102.9M	2,651.72%79.8M	247.66%81.7M	2,200.00%2.1M	-129.08%-4.1M	100.29%100K	114.22%2.9M	-12.64%23.5M	-100.40%-100K	155.73%14.1M
-Change in receivables	----	111.73%6.9M	----	----	----	----	-1,570.00%-58.8M	----	----	----
-Change in inventory	----	-249.52%-62.8M	----	----	----	----	411.11%42M	----	----	----
-Change in payables and accrued expense	----	517.24%17.9M	----	----	----	----	-34.09%2.9M	----	----	----
-Change in other current assets	----	267.24%9.7M	----	----	----	----	72.77%-5.8M	----	----	----
-Change in other working capital	----	378.32%108.1M	----	----	----	----	276.67%22.6M	----	----	----
Cash from discontinued investing activities
Operating cash flow	-30.53%89.9M	15.52%754.8M	32.09%251.1M	9.49%197.2M	7.33%177.1M	9.48%129.4M	-15.85%653.4M	-20.49%190.1M	-21.73%180.1M	-2.48%165M
Investing cash flow
Cash flow from continuing investing activities	40.11%-42.7M	24.50%-285.9M	27.39%-76.1M	22.90%-63.3M	25.69%-75.2M	21.30%-71.3M	-2.71%-378.7M	3.68%-104.8M	14.21%-82.1M	-23.26%-101.2M
Capital expenditure reported	40.11%-42.7M	24.16%-285.9M	27.45%-76.1M	22.14%-63.3M	24.95%-75.2M	21.30%-71.3M	-4.14%-377M	3.50%-104.9M	15.14%-81.3M	-32.89%-100.2M
Net other investing changes	----	----	----	----	----	----	74.63%-1.7M	200.00%100K	-900.00%-800K	----
Cash from discontinued investing activities
Investing cash flow	40.11%-42.7M	24.50%-285.9M	27.39%-76.1M	22.90%-63.3M	25.69%-75.2M	21.30%-71.3M	-2.71%-378.7M	3.68%-104.8M	14.21%-82.1M	-23.26%-101.2M
Financing cash flow
Cash flow from continuing financing activities	-110.00%-308.7M	70.27%-185.1M	83.02%-11.7M	82.14%-11.5M	93.17%-14.9M	45.76%-147M	-35.47%-622.6M	63.64%-68.9M	-188.79%-64.4M	-23.47%-218.3M
Net issuance payments of debt	-50.00%-300K	96.01%-1.1M	-200.00%-300K	91.43%-300K	98.71%-300K	71.43%-200K	-1,050.00%-27.6M	85.71%-100K	-483.33%-3.5M	-4,560.00%-23.3M
Net common stock issuance	-120.66%-300.1M	75.86%-136.8M	99.63%-200K	99.81%-100K	99.73%-500K	50.07%-136M	-25.58%-566.6M	69.17%-54.6M	-86.48%-52.4M	-7.34%-187.2M
Cash dividends paid	-3.95%-15.8M	-3.55%-61.2M	-3.27%-15.8M	-4.14%-15.1M	-3.42%-15.1M	-3.40%-15.2M	-3.68%-59.1M	-3.38%-15.3M	-3.57%-14.5M	-3.55%-14.6M
Proceeds from stock option exercised by employees	70.45%7.5M	-44.34%18.2M	48.39%4.6M	-33.33%4M	-23.53%5.2M	-73.81%4.4M	-35.88%32.7M	0.00%3.1M	-70.59%6M	-44.26%6.8M
Net other financing activities	----	-110.00%-4.2M	--0	--0	----	----	---2M	----	----	----
Cash from discontinued financing activities
Financing cash flow	-110.00%-308.7M	70.27%-185.1M	83.02%-11.7M	82.14%-11.5M	93.17%-14.9M	45.76%-147M	-35.47%-622.6M	63.64%-68.9M	-188.79%-64.4M	-23.47%-218.3M
Net cash flow
Beginning cash position	63.29%791.3M	-43.25%484.6M	28.03%628.5M	14.23%509.7M	-32.83%404.2M	-43.25%484.6M	-4.52%853.9M	-45.37%490.9M	-43.97%446.2M	-32.10%601.8M
Current changes in cash	-194.15%-261.5M	181.58%283.8M	895.73%163.3M	264.29%122.4M	156.31%87M	63.48%-88.9M	-571.62%-347.9M	127.70%16.4M	-70.03%33.6M	-72.24%-154.5M
Effect of exchange rate changes	-198.82%-8.4M	207.01%22.9M	97.80%-500K	-132.43%-3.6M	1,781.82%18.5M	197.70%8.5M	-287.72%-21.4M	-256.55%-22.7M	213.27%11.1M	-266.67%-1.1M
End cash Position	29.00%521.4M	63.29%791.3M	63.29%791.3M	28.03%628.5M	14.23%509.7M	-32.83%404.2M	-43.25%484.6M	-43.25%484.6M	-45.37%490.9M	-43.97%446.2M
Free cash flow	-18.76%47.2M	69.65%468.9M	105.40%175M	35.53%133.9M	57.25%101.9M	110.51%58.1M	-33.32%276.4M	-34.66%85.2M	-26.43%98.8M	-30.92%64.8M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

United Microelectronics

Middle East conflict spreads to the stock market! How should investors respond?

According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm